You are wrong on so many levels, BARDA, Military and other arms of the government who in the long run will be 50% of AVH business will not allow it. Second costs associated with producing a knock off then trying to get it into the hospital system here in the US will be cost prohibitive. But you go ahead and believe what you wish, big difference in a pill and something like ReCell.
- Forums
- ASX - By Stock
- AVH
- Patent extension
Patent extension, page-14
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M |
Open | High | Low | Value | Volume |
$3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $3.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.84 | 11883 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 3.770 |
1 | 266 | 3.750 |
2 | 3270 | 3.700 |
3 | 1300 | 3.650 |
2 | 641 | 3.600 |
Price($) | Vol. | No. |
---|---|---|
3.850 | 5926 | 1 |
3.860 | 9868 | 1 |
3.880 | 902 | 1 |
3.900 | 4000 | 1 |
3.930 | 5200 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online